Newborn Screening by Tandem Mass Spectrometry: Gaining Experience

Major expansion of newborn screening for inherited met-abolic disorders is taking place across the US and around the world as newer analytical technology is applied. Historically, each disorder to be screened required a separate test with associated costs and requirement for a portion of the dri...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Sweetman, Lawrence
Formato: Artículo
Lenguaje:Inglés
Publicado: Universidad de Belgrano - Documentos CEEGMD - Centro para el estudio de enfermedades genéticas, metabólicas y discapacidades. Facultad de Ciencias Exactas 2014
Materias:
Acceso en línea:http://repositorio.ub.edu.ar/handle/123456789/2873
Aporte de:
Descripción
Sumario:Major expansion of newborn screening for inherited met-abolic disorders is taking place across the US and around the world as newer analytical technology is applied. Historically, each disorder to be screened required a separate test with associated costs and requirement for a portion of the dried-blood-spot specimen from a heel stick. This limitation of the existing tests was partially responsible for the limitation of mandated newborn screening in the US to a small number of disorders (usually three to seven, depending on the state).